Dominion just posted six straight earnings beats while its data center pipeline swells past 53 gigawatts, but Virginia regulators are threatening a freeze that could gut the base-rate growth powering the whole story.
Dominion Energy (NYSE:D | D Price Prediction) is expected to report third-quarter results before the market opens on Friday, October 30. Record data center demand continues raising earnings. At the same time, Virginia officials want a six-year base-rate freeze as the price of the NextEra Energy (NYSE:NEE) merger.
Six Straight Beats Run Into a Political Wall Last quarter, Dominion posted operating EPS of $0.79 against a $0.68 consensus. That made six beats in a row. Revenue rose 17.6% YoY to $4.48B, and Dominion Energy Virginia’s operating earnings climbed to $670M from $549M on Biennial Review effects and rider equity returns. GAAP results looked worse. Nonregulated impairments of $626M cut net income to $340M.
Management reaffirmed 2026 operating EPS guidance of $3.45 to $3.69. Since then, the politics around the deal with NextEra have hardened. Governor Abigail Spanberger and State Corporation Commission staff oppose the merger. They are demanding a six-year base-rate freeze and tripled customer credits. Even so, shares have gained 14.73% year to date, to $65.20.
Consensus Calls for Double-Digit EPS Growth Metric Consensus Prior Year YoY Growth Q3 2026 EPS $1.1933 $1.06 12.6% Q3 2026 Revenue $4.80B $4.53B 6.1% FY 2026 EPS $3.5857 $3.42 4.8% FY 2026 Revenue $18.16B $16.5B 10.0% The Q3 EPS estimate has slipped from $1.2059 60 days ago. Analysts made two downward revisions in the past month.
Freeze Talk and the 53 GW Pipeline Will Set the Tone Mostly, I’ll be watching how management responds to the freeze demand before Virginia’s formal hearings begin November 17. Rider returns and base-rate increases drove this year’s Virginia gains, and a six-year freeze would cap the base-rate side. In July, Robert Blue pushed back: “We don’t think it makes sense to change the rules in the middle of the game.”
Demand remains the strongest card Dominion holds. The utility has over 53 gigawatts of data center capacity in various stages of contracting, with about 12 gigawatts under electric service agreements. You should track whether that signed figure continues rising, because signed contracts are what turn into rate base.
Offshore wind is the third test. The Coastal Virginia Offshore Wind project was 81% complete, with costs revised to $11.65 billion and final turbine installation pushed back 6 months. Any further decline would matter.
Finally, watch the new resource plan. It proposes nearly 9 GW of new gas plants and only 3.5 GW of battery storage, against Virginia’s 16 GW storage mandate. Dominion has also sued Prince William County after local supervisors blocked a substation overhaul.
A Freeze Would Rewrite the Growth Math Dominion’s target of 5% to 7% annual EPS growth through 2030 depends on a $64.7B capital plan making regulated returns. The demand is clearly there. What’s uncertain is how much of that spending regulators will let Dominion recover. If management shows a merger path that avoids punishing freeze terms, the rally has support. If those terms stick, the company’s stated lean toward the upper half of its range for 2028 to 2030 becomes much harder to defend.
Contact [email protected] for any questions or corrections.
SAN FRANCISCO, CALIFORNIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) cell engager platform, today announced that it has been selected for an oral presentation at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting taking place from November 4-8, 2026 in Phoenix, AZ.
Oral Presentation Details
Presentation Title: Inhibition of the KRAS oncoprotein sensitizes pancreatic cancer to NK cell immunotherapy
Abstract No.: 655
Presenter: Paarth Dodhiawala, University of Minnesota Medical School1
Presentation Date: Friday, November 6, 2026
Presentation Time: 3:05-3:20 PM MT
Location: North Building – 300 Level – Halls BC
Session 106a: Combination Therapies Involving Cell Therapy, 1:45-3:25 PM MST
Session Description: While cell therapy has transformed the treatment of certain hematologic malignancies, its impact in solid tumors remains limited by antigen heterogeneity, immunosuppressive microenvironments, and nutrient deprivation. As efforts to engineer more effective immune cells continue, there is growing interest in combining cell therapies with complementary approaches to enhance their function and engage endogenous immunity. This session will highlight diverse strategies to extend the clinical impact of cell therapies through rational combination approaches.
Session Schedule: https://www.sitcancer.org/2026/schedule/sitc-2026-schedule#session-1596
About GT Biopharma, Inc.
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on our proprietary TriKE® NK cell engager platform. Our TriKE® platform is designed to harness and enhance the cancer killing abilities of a patient’s immune system’s natural killer cells. GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE® technology. For more information, please visit gtbiopharma.com.
Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in our most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and we undertake no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to our filings with the Securities and Exchange Commission.
TriKE® is a registered trademark owned by GT Biopharma, Inc.
1 The University of Minnesota, pursuant to its license agreement with GT Biopharma, is entitled to receive royalties should commercial sales of product using the TriKE technology be realized, including GTB-3650 and GTB-5550. This interest has been reviewed and managed by the University of Minnesota in accordance with its conflict of interest policies.
Key Takeaways HMC gained 8.1% after its Zacks Rank upgrade, while BILL returned 6.3% in the same period.CACI surged 31.9% over 12 weeks, while Ulta Beauty climbed 30.7%, outpacing the S&P 500.ACN jumped 79.7% over 12 weeks, while CHKP gained 26.2% in the same period. The three benchmark Wall Street indexes delivered mixed performance for the week ended October 23. The tech-focused Nasdaq Composite fell 0.7%, while the S&P 500 declined 0.5%. The Dow Jones Industrial Average, however, added 0.4% to mark a third straight week of gains.
Technology shares faced heavy selling as investors questioned whether massive artificial intelligence investments would generate sufficient returns, with concerns about financing costs adding to pressure. Renewed Middle East tensions pushed oil prices higher, reviving inflation fears and uncertainty over interest rates. Defensive sectors and value-oriented stocks helped limit broader market losses.
Investor sentiment remained cautious despite generally supportive corporate earnings. With major technology companies preparing to report results and the Federal Reserve’s policy meeting approaching, investors were closely monitoring capital-spending plans, profit outlooks and interest-rate signals.
Regardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the market.
As usual, Zacks Research guided investors over the past three months with its time-tested methodologies. Given the prevailing market uncertainty, you may want to look at our feats to prepare better for your next action.
Here are some of our key achievements:
Honda Motor and BILL Surge Following Zacks Rank UpgradeShares of Honda Motor Co., Ltd. (HMC - Free Report) have gained 8.1% (versus the S&P 500’s 2.2% decrease) since it was upgraded to a Zacks Rank #1 (Strong Buy) on August 17.
Another stock, BILL Holdings, Inc. (BILL - Free Report) , which was also upgraded to a Rank #1 on August 26, has returned 6.3% since then.
A portfolio of Zacks # 1 Rank (Strong Buy) stocks has outperformed the S&P 500 index by 3.9 percentage points this year. Through October 5th this year, the Zacks # 1 Rank portfolio returned +16.9%, which compares to a +13% gain for the S&P 500 index and an +8.1% gain for the equal-weight version of the index in the same time period.
Since its inception in 1988, this portfolio of Zacks # 1 Rank stocks has outperformed the market by 12.2 percentage points. The average annual return for this portfolio of Zacks # 1 Rank stocks since inception in 1988 was +23.8% through October 5th, which compares to a +11.6% gain for the S&P 500 index and a +11.2% gain for the equal-weight version of the index.
You can see the complete list of today’s Zacks Rank #1 stocks here >>>
Check Honda Motor’s historical EPS and Sales here>>>
Check BILL’s historical EPS and Sales here>>>
Zacks Recommendation Upgrades Telos and NIQ GlobalShares of Telos Corporation (TLS - Free Report) and NIQ Global Intelligence plc (NIQ - Free Report) have surged 9.9% and 9.3% (versus the S&P 500’s 1.2% fall), respectively, since their Zacks Recommendation was upgraded to Outperform on August 5.
While the Zacks Rank is our short-term rating system that is most effective over the one- to three-month holding horizon, the Zacks Recommendation aims to predict performance over the next 6 to 12 months. However, just like the Zacks Rank, the foundation for the Zacks Recommendation is trends in earnings estimate revisions.
The Zacks Recommendation classifies stocks into three groups — Outperform, Neutral and Underperform. While these recommendations are determined quantitatively, our analysts have the flexibility to override them for the 1100+ stocks they closely follow based on their better judgment of factors such as valuation, industry conditions and management effectiveness than the quantitative model.
To access our research reports with Zacks Recommendations for the 1100+ stocks we cover, click here>>>
Zacks Focus List Stocks CACI & Ulta Beauty Shoot UpShares of CACI International Inc. (CACI - Free Report) , which belongs to the Zacks Focus List, have soared 31.9% over the past 12 weeks. The stock was added to the Focus List on December 2, 2015. Another Focus-List holding, Ulta Beauty, Inc. (ULTA - Free Report) , which was added to the list on March 25, 2020, has returned 30.7% over the past 12 weeks. The S&P 500 has advanced 2.9% over this period.
The 50-stock Focus List portfolio returned +13.78% in the year-to-date period (through September 30th, 2026) vs. +12.75% for the S&P 500 index and +10.03% for the equal-weight version of the index.
The portfolio returned +22.1% in 2025 vs. +17.9% for the S&P 500 index and +11.4% for the equal-weight version of the index.
The Zacks Focus List portfolio returned +18.41% in 2024 vs. +25.04% for the S&P 500 index and +13% for the equal-weight S&P 500 index. The portfolio had returned +29.54% in 2023 vs. +26.28% for the S&P 500 index and +13.61% for the equal-weight S&P 500 index. In 2022, the portfolio returned -15.2% vs. the S&P 500 index’s -17.96%.
Through September 30th, 2026, the portfolio’s rolling returns on a one-year, three-year, five-year, ten-year, and since 2004 have been +17.49% (vs. +15.74% for the S&P 500 index), +24.4% (vs. +22.9%), +13.5% (vs. +13.8%), +16.4% (vs. +15.3%) and +12.4% vs. (+10.9%), respectively.
Unlock all of our powerful research, tools and analysis, including the Focus List, Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. Gain full access now >>
Zacks ECAP Stocks Accenture & Check Point Gain SignificantlyAccenture plc (ACN - Free Report) , a component of our Earnings Certain Admiral Portfolio (ECAP), has jumped 79.7% over the past 12 weeks. Check Point Software Technologies Ltd. (CHKP - Free Report) followed Accenture with 26.2% returns.
The Zacks Earnings Certain Admiral Portfolio (ECAP), which consists of 30 concentrated, ultra-defensive, long-term Buy-and-Hold stocks, returned -4.7% in 2026 (through September 30th, 2026) vs. +12.75% for the S&P 500 index.
For 2025, the portfolio returned -1.67% vs. a +17.9% gain for the S&P 500 index. For the year 2024, the portfolio returned +16.26% vs. +24.89% for the S&P 500 index (SPY ETF). In 2023, the portfolio returned +12.17% vs. +26.28% for the S&P 500 index. The portfolio returned -4.7% in 2022 vs. the S&P 500 index’s -17.96%.
With little to no turnover and annual rebalance periodicity, ECAP seeks to minimize capital loss by holding shares of companies whose earnings streams exhibit a proven 20+ year track record of surviving recessionary periods with minimal impact on aggregate earnings growth relative to the overall S&P 500.
The ECAP and many other model portfolios are available as part of Zacks Advisor Tools, a cloud-based solution to access Zacks award-winning stock, mutual fund and ETF research. Click here to schedule a demo.
Zacks ECDP Stocks Automatic Data Processing & Procter & Gamble Outperform PeersAutomatic Data Processing, Inc. (ADP - Free Report) , which is part of our Earnings Certain Dividend Portfolio (ECDP), has returned 25.2% over the past 12 weeks. Another ECDP stock,The Procter & Gamble Company (PG - Free Report) , has climbed 9.6% over the same time frame. Of course, the inclination of investors toward quality dividend stocks to secure an income stream amid heightened market volatility contributed to this performance.
Check Automatic Data Processing’ dividend history here>>>
Check Procter & Gamble’s dividend history here>>>
With an extremely low beta and a history of minimum earnings variability over the last 20+ years, this 25-stock portfolio helps significantly mitigate risk.
The Zacks Earnings Certain Dividend Portfolio (ECDP) returned +2.01% in the year-to-date period (through September 30th) vs. +12.75% for the S&P 500 index.
The portfolio returned -0.6% in 2025 vs. a +6.8% gain for the Dividend Aristocrats ETF. For the full year 2024, the portfolio returned +6.95% vs. +24.89% for the S&P 500 index and +6.72% for NOBL. The portfolio returned -0.9% in 2023 vs. +26.28% for the S&P 500 index and +8.11% for NOBL. The portfolio returned -2.3% in 2022 vs. -17.96% for the S&P 500 index and -8.34% for NOBL.
Click here to access this portfolio on Zacks Advisor Tools.
Zacks Top 10 Stock Monolithic Power Delivers Solid ReturnsMonolithic Power Systems, Inc. (MPWR - Free Report) , from the Zacks Top 10 Stocks for 2025, has jumped 21.8% since January 5, 2026, compared with the S&P 500 Index’s 11.2% increase.
The Top 10 portfolio returned +8.34% in the year-to-date 2026 period (through September 30th) vs. +12.75% for the S&P 500 index and +10.03% for the equal-weight version of the index.
The Top 10 portfolio returned +22.6% in 2025 vs. +17.9% for the S&P 500 index and +11.4% for the equal-weight version of the index.
The Top 10 portfolio returned +62.98% in 2024, vs. +25.04% for the S&P 500 index and +13% for the equal-weight version of the index. The portfolio had returned +25.15% in 2023 vs. +26.28% for the S&P 500 index.
Through the end of September 2026, the Top 10 portfolio has produced a cumulative return of +2,706.5% since 2012 vs. +645.9% for the S&P 500 index and +453.8% for the equal-weight version of the index. The portfolio has produced an average annual return of +25.1% in the period 2012 through September 30th, 2026, vs. +13.5% for the S&P 500 index and +10.8% for the equal-weight version of the index.
SAN FRANCISCO, Oct. 26, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP reminds Monolithic Power Systems, Inc. (NASDAQ: MPWR) investors that the firm is investigating potential wrongdoing at the company following a 30% stock drop and court rulings that key claims in a securities fraud lawsuit against Monolithic Power and its CEO and former CFO will move forward. Current shareholders are encouraged to contact the firm here: https://www.classactionlawyers.com/monolithicreminder.
New York, New York--(Newsfile Corp. - October 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/cases/azenta-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
WHAT IS THIS ABOUT: On August 24, 2026, Azenta filed with the SEC a current report on Form 8-K which stated that on "August 22, 2026, John P. Marotta resigned as President and Chief Executive Officer of Azenta, Inc. (the "Company") and as a member of the Company's Board of Directors (the "Board"), effective as of August 22, 2026 (the "Effective Date")."
On this news, Azenta's stock fell 12% on August 24, 2026.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/320811
Source: The Rosen Law Firm PA
Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Public safety and cybersecurity both rely on mission-critical technology to protect essential assets. Deciding between Axon Enterprise (AXON -0.76%) and CrowdStrike (CRWD -0.72%) requires weighing physical security dominance against digital defense leadership.
Axon transforms law enforcement through Taser devices and body cameras, while CrowdStrike secures the cloud using its Falcon platform. Both companies command premium valuations due to their sticky, recurring revenue models. Investors often compare them because they both provide essential protection services that are difficult for customers to replace.
The case for Axon EnterpriseAxon Enterprise operates in a specialized area often associated with defense stocks, serving public and private safety professionals globally. The company sells hardware like Taser devices and body cameras alongside cloud-based software for evidence management and real-time operations. According to its latest annual report, no single customer accounted for more than 10% of total net sales, which reduces the impact of any individual contract loss.
In the fiscal year ended Dec. 31, 2025, revenue reached approximately $2.8 billion, representing a growth rate of nearly 33.5% compared with the prior fiscal year. The company reported net income of close to $124.9 million for the same period. Its net margin, which measures the percentage of revenue remaining as profit after all expenses, was roughly 4.5%.
As of its December 2025 balance sheet, the debt-to-equity ratio is approximately 0.6x, meaning its total debt is 60% of its shareholder equity. The current ratio is roughly 2.5x, which measures its ability to pay short-term debts with assets that can be converted to cash quickly. Free cash flow reached nearly $75.1 million in its latest fiscal year. Note that stock-based compensation represented roughly 300.1% of operating cash flow, meaning reported cash generation is heavily inflated by this non-cash add-back.
The case for CrowdStrikeCrowdStrike provides cloud-native cybersecurity through its Falcon platform, which includes 34 different software modules for endpoint protection and identity security. It serves over 88,000 organizations and maintains strategic partnerships with hardware leaders like Nvidia. The company utilizes a software-as-a-service model to generate recurring revenue from global enterprise and government clients seeking to prevent digital breaches.
In the fiscal year ended Jan. 31, 2026, revenue reached nearly $4.8 billion, which is an increase of roughly 21.7% year over year. However, the company reported a net loss of approximately $162.5 million during this period. This resulted in a negative net margin of roughly 3.4%, indicating that its total expenses exceeded its total revenue for the latest fiscal year.
As of its January 2026 balance sheet, the debt-to-equity ratio is close to 0.2x, which indicates a relatively low level of debt compared to its equity. Its current ratio is approximately 1.8x, measuring its liquid assets against its upcoming obligations. Free cash flow for the period was roughly $1.3 billion. Note that stock-based compensation represented roughly 68% of operating cash flow, which inflates reported cash generation since SBC is a non-cash expense added back in the cash flow statement.
Risk profile comparisonAxon Enterprise is substantially dependent on law enforcement agencies, and shifts in government budgetary priorities could reduce demand for its products. The company also faces competition from established players like Motorola Solutions in the public safety market. Additionally, it relies on domestic and international suppliers for critical components, which creates vulnerability to supply chain disruptions and geopolitical volatility.
CrowdStrike continues to face adverse effects from its July 19, 2024, configuration update failure, which resulted in system crashes and ongoing class action litigation. The company also faces pressure from competitors who may drive pricing lower to gain market share in the fragmented security software market. Furthermore, because its platform is hosted on infrastructure provided by Amazon, any disruptions at those facilities could lead to service outages.
Valuation comparisonCrowdStrike carries a significantly higher valuation on both earnings and sales metrics, reflecting higher growth expectations despite its recent net loss.
MetricAxon EnterpriseCrowdStrikeForward P/E54.0x189.8xP/S ratio10.5x45.1xValuation metrics include sourcing from Financial Modeling Prep (FMP) and may differ from other data providers.
Which stock would I buy in 2026?Axon's business and more affordable stock valuation make it an appealing choice in this matchup of physical vs. digital security players.
Axon's stock has repriced lower over the last year, down more than 45% year over year as of Oct. 26. The decline was mainly driven by a broad market adjustment of software and software-as-a-service (SaaS) stocks as the market considers how autonomous AI agents and copilots could reshape these businesses. It also recently completed a $1 billion offering of convertible senior notes, plus an option for up to $150 million more, diluting existing shareholders. Several analyst groups are lowering their price targets on the stock in response to valuation concerns. But none of these changes reflects fundamental weakness or disappointing quarterly results out of Axon.
But Axon has developed a wide economic moat, providing both hardware and software to law enforcement agencies that would be difficult and costly to switch. Since the end of 2019, the company has delivered 25% revenue growth or better in every quarter except one. And despite the analyst rerating, the average analyst price target is between $681.70 and $697.59, with a high forecast of $830.00. At a current price around $420, Axon looks like a solid buy-the-dip candidate right now.
RADNOR, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the third quarter of 2026 before market open on Thursday, November 5th, 2026. Company management will host a conference call to discuss financial results at 8:30AM ET.
To listen by phone, investors may dial 800-715-9871 (646-307-1963 for international callers) and enter access code 2208277. The live webcast will be available through the Certara Earnings Webcast link and the Investor Relations section of the Company’s website at ir.certara.com, where a replay will be archived.
About Certara
Certara transforms drug discovery and development for good, helping scientists and clinical teams generate regulatory-grade evidence faster. Its solutions combine biosimulation, clinical intelligence, and regulatory science, and are embedded in the workflows of drug developers worldwide. Certara clients include more than 2,600 biopharmaceutical companies, academic institutions, and global regulatory agencies. Learn more at certara.com.
Expanding Acuity’s Data Center Portfolio from Edge Control to Leak Detection, Sensing and Monitoring
Parameter is a Leader in Data Center Leak Detection, a Fast-Growing Market Driven by the Shift to Liquid CoolingTransaction Expected to Close in the Second Quarter of Fiscal 2027 and be Accretive to Acuity Fiscal 2027 Full-Year Adjusted Diluted Earnings per Share ATLANTA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE: AYI) (the "Company" or "Acuity") has reached a definitive agreement to acquire Parameter Technologies ("Parameter") for a purchase price of $675 million. It is expected to be accretive to Acuity's fiscal 2027 full-year adjusted diluted earnings per share.
Parameter provides mission-critical leak detection, environmental monitoring and battery monitoring solutions for data centers and other critical infrastructure. Its accurate, location-specific leak detection capabilities help customers identify issues earlier, reduce disruption and protect critical equipment as data centers adopt more complex liquid cooling systems. Upon closing, Parameter will become part of Distech ControlsTM within Acuity Intelligent Spaces. Parameter shares Distech’s go-to-market channels, which include system integrators and distributors, and will deepen Distech’s relationships with cooling equipment OEMs.
“Parameter has built a high-performing business that is highly complementary to Distech’s portfolio,” said Peter Han, President of Acuity Intelligent Spaces. “By combining Parameter’s sensing, detection and monitoring technology with Distech’s edge controls, we expand our capabilities in data centers and deepen relationships with channel partners. This builds on Distech’s proven ability to solve customer problems and scale adjacent technologies that support durable growth for Acuity Intelligent Spaces.”
Parameter expects to deliver sales of approximately $100 million for calendar 2027, representing growth of more than 30 percent year-over-year, and EBITDA margins of approximately 40 percent. The acquisition is expected to be accretive to Acuity Intelligent Spaces revenue growth and margins.
“We have built our business around technology that customers trust to protect critical equipment,” said Michael Blazes, Chief Executive Officer of Parameter. “Joining Acuity allows us to build on that success. Together, we can bring our technology to more applications, help customers identify issues earlier and take action to better protect their operations.”
Acquisition Financing and Close
We anticipate funding the transaction using $500 million in borrowings and the remainder with cash on the balance sheet. The transaction is expected to close in the second quarter of fiscal 2027, subject to customary closing conditions, including, among others, the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.
PJT Partners is serving as financial advisor to Acuity and Baker McKenzie is providing external legal counsel. J.P. Morgan and Bank of America are leading the financing.
About Acuity
Acuity Inc. (NYSE: AYI) is a market-leading industrial technology company. We use technology to solve problems in spaces, light and more things to come. Through our two business segments, Acuity Brands Lighting (ABL) and Acuity Intelligent Spaces (AIS), we design, manufacture, and bring to market products and services that make a valuable difference in people’s lives.
We achieve growth through the development of innovative new products and services, including lighting, lighting controls, building management solutions, and an audio, video and control platform. We focus on customer outcomes and drive growth and productivity to increase market share and deliver superior returns. We look to aggressively deploy capital to grow the business and to enter attractive new verticals.
Acuity Inc. is based in Atlanta, Georgia, with operations across North America, Europe and Asia. The Company is powered by approximately 13,000 dedicated and talented associates. Visit us at www.acuityinc.com.
About Parameter Technologies
Parameter Technologies develops monitoring and detection solutions for data centers, utilities and critical infrastructure. Through its RLE Technologies and CellWatch brands, Parameter provides leak detection, environmental monitoring and battery monitoring solutions that help facility operators protect performance and minimize costly downtime. Parameter is headquartered in Fort Collins, Colorado, with engineering and service operations in Raleigh, North Carolina, and sales and service capabilities in Milton Keynes, United Kingdom.
Forward-Looking Information
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include, but are not limited to, statements that describe or relate to our plans, initiatives, projections, vision, goals, targets, commitments, expectations, objectives, prospects, strategies, or financial outlook, and the assumptions underlying or relating thereto. In some cases, we may use words such as "expect," "believe," "intend," "anticipate," "estimate," "forecast," "indicate," "project," "predict," "plan," "may," "will," "could," "should," "would," "potential," and words of similar meaning, as well as other words or expressions referencing future events, conditions, or circumstances, to identify forward-looking statements. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Act. Forward-looking statements are not guarantees of future performance. Our forward-looking statements are based on our current beliefs, expectations, and assumptions, which may not prove to be accurate, and are subject to known and unknown risks and uncertainties, assumptions, and other important factors, many of which are outside of our control and any of which could cause our actual results to differ materially from those expressed or implied by the forward-looking statements. These risks and uncertainties are discussed in our filings with the U.S. Securities and Exchange Commission, including our most recent annual report on Form 10-K (including, but not limited to, the sections titled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations"), quarterly reports on Form 10-Q, and current reports on Form 8-K. Any forward-looking statement speaks only as of the date on which it is made. This press release is not comprehensive, and for that reason, should be read in conjunction with such filings. You are cautioned not to place undue reliance on any forward-looking statements. Except as required by law, we undertake no obligation to publicly update or release any revisions to these forward-looking statements to reflect any events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events, or otherwise.
Connecting Mission-Critical Sensing, Detection and Monitoring Technology with Edge Controls
Parameter Will Become Part of Distech Controls Within Acuity Intelligent Spaces upon ClosingCombining Parameter’s Sensing, Detection and Monitoring Technology With Distech’s Edge Controls Will Help Customers Detect Problems and Resolve Issues Earlier FORT COLLINS, Colo.--(BUSINESS WIRE)--Parameter Technologies (“Parameter”) today announced that it has entered into a definitive agreement to be acquired by Acuity Inc. (NYSE: AYI) (“Acuity”) for a purchase price of $675 million. Upon closing, Parameter will become part of Distech Controls within the Acuity Intelligent Spaces business segment.
Distech is a leader in building controls, combining open protocols and tools with edge controls, cloud intelligence and an open go-to-market model. Parameter will benefit from access to this technology and Acuity’s scale, while building on our existing work with Distech across shared system integrator, distributor and cooling equipment OEM relationships. Together, Distech and Parameter can connect our sensing, detection and monitoring technology with Distech’s controls to help customers to be able to detect problems and resolve issues earlier and better protect mission-critical operations.
“We have built our business around technology that customers trust to protect critical equipment,” said Michael Blazes, Chief Executive Officer of Parameter. “Joining Acuity allows us to build on that success. Together, we can bring our technology to more applications, help customers identify issues earlier and take action to better protect their operations.”
“Parameter has built a high-performing business that is highly complementary to Distech’s portfolio,” said Peter Han, President of Acuity Intelligent Spaces. “By combining Parameter’s sensing, detection and monitoring technology with Distech’s edge controls, we expand our capabilities in data centers and deepen relationships with channel partners. This builds on Distech’s proven ability to solve customer problems and scale adjacent technologies that support durable growth for Acuity Intelligent Spaces.”
Transaction Close
The transaction is expected to close in late 2026, subject to customary closing conditions, including, among others, the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. Until the transaction closes, Parameter and Acuity will continue to operate independently, and Parameter will remain focused on serving its customers and partners.
Lincoln International is serving as lead financial advisor to Parameter and Paul Hastings is providing external legal counsel.
About Acuity
Acuity Inc. (NYSE: AYI) is a market-leading industrial technology company. We use technology to solve problems in spaces, light and more things to come. Through our two business segments, Acuity Brands Lighting (ABL) and Acuity Intelligent Spaces (AIS), we design, manufacture, and bring to market products and services that make a valuable difference in people’s lives.
We achieve growth through the development of innovative new products and services, including lighting, lighting controls, building management solutions, and an audio, video and control platform. We focus on customer outcomes and drive growth and productivity to increase market share and deliver superior returns. We look to aggressively deploy capital to grow the business and to enter attractive new verticals.
Acuity Inc. is based in Atlanta, Georgia, with operations across North America, Europe and Asia. The Company is powered by approximately 13,000 dedicated and talented associates. Visit us at www.acuityinc.com.
About Parameter Technologies
Parameter Technologies develops monitoring and detection solutions for data centers, utilities and critical infrastructure. Through its RLE Technologies and CellWatch brands, Parameter provides leak detection, environmental monitoring and battery monitoring solutions that help facility operators protect performance and minimize costly downtime. Parameter is headquartered in Fort Collins, Colorado, with engineering and service operations in Raleigh, North Carolina, and sales and service capabilities in Milton Keynes, United Kingdom.
Throughout 2025, Duolingo pushed monetization by adding friction to its free app: bookings grew 33%, but daily user growth slowed from 49% to ~30%. In February 2026, management reversed course and gave up more than $50 Million of 2026 bookings to grow users again, targeting 100 Million DAUs in 2028. DAU growth has reaccelerated from 21% to 23% in H1 2026, while Advertising and in-app purchase revenue, the lines most tied to friction, are shrinking.
Deckers (DECK - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Shares of this maker of Ugg footwear have returned +3.1% over the past month versus the Zacks S&P 500 composite's -1.2% change. The Zacks Retail - Apparel and Shoes industry, to which Deckers belongs, has gained 9% over this period. Now the key question is: Where could the stock be headed in the near term?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current quarter, Deckers is expected to post earnings of $3.52 per share, indicating a change of +5.7% from the year-ago quarter. The Zacks Consensus Estimate has changed -1.3% over the last 30 days.
For the current fiscal year, the consensus earnings estimate of $7.69 points to a change of +9.5% from the prior year. Over the last 30 days, this estimate has changed +3.7%.
For the next fiscal year, the consensus earnings estimate of $8.2 indicates a change of +6.6% from what Deckers is expected to report a year ago. Over the past month, the estimate has changed -1.4%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Deckers.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For Deckers, the consensus sales estimate for the current quarter of $2.12 billion indicates a year-over-year change of +8.2%. For the current and next fiscal years, $5.79 billion and $6.19 billion estimates indicate +5.7% and +7% changes, respectively.
Last Reported Results and Surprise HistoryDeckers reported revenues of $1.48 billion in the last reported quarter, representing a year-over-year change of +3.5%. EPS of $2.03 for the same period compares with $1.82 a year ago.
Compared to the Zacks Consensus Estimate of $1.51 billion, the reported revenues represent a surprise of -1.98%. The EPS surprise was +11.54%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Deckers is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Deckers. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Key Takeaways Raymond James' Q4 earnings are projected to rise 5.5%, with revenues expected to grow 12.3% year over year.RJF's trading revenues are poised to gain from heightened market volatility and increased client activity.RJF's investment banking fees are expected to fall 4.9%, while NII is projected to rise 2.9%.
Raymond James (RJF - Free Report) is set to announce fourth-quarter and full-year fiscal 2026 (ended Sept. 30) results on Oct. 28, after market close. The company’s quarterly earnings and revenues are expected to have risen on a year-over-year basis.
In the last reported quarter, RJF’s earnings surpassed the Zacks Consensus Estimate. Results benefited primarily from an increase in revenues to record levels and robust growth in the assets under administration balance. However, higher expenses were the undermining factor.
Raymond James has an impressive earnings surprise history. Its earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, with the average beat being 6.67%.
The Zacks Consensus Estimate for the company’s fiscal fourth-quarter earnings is pegged at $3.28, unchanged over the past week. The figure indicates an increase of 5.5% from the year-ago quarter.
The consensus estimate for sales of $4.19 billion suggests 12.3% year-over-year growth.
Management expects fiscal third-quarter asset management and related administrative fees to grow 11% sequentially, driven by higher Private Client Group assets and fee-based accounts balance at quarter end.
Factors to Influence Raymond James’ Q4 EarningsInvestment Banking (IB) Fees: After an impressive performance in the last few quarters, global deal-making activity moderated in the September quarter, weighed down by elevated interest rates, persistent inflation and geopolitical uncertainties that complicated valuations and deal negotiations. Still, strategic buyers continued to pursue acquisitions to strengthen scale, operational resilience and supply-chain security amid a challenging business environment. So, overall global mergers and acquisitions (M&As) volume and value were muted as only a handful of big transactions dominated the space. This is expected to have hurt RJF’s advisory fees in the quarter.
IPO activity remained robust in the to-be-reported quarter, with proceeds climbing to a five-year high, despite a year-over-year decline in the number of deals. Meanwhile, global equity and debt issuance activity lost momentum as geopolitical uncertainties, persistent inflation and fluctuating energy prices dampened investor risk appetite. So, RJF’s underwriting fees are expected to have declined on a year-over-year basis.
The Zacks Consensus Estimate for the company’s total IB fees for the fiscal fourth quarter is pegged at $300.5 million, indicating a 4.9% decrease on a year-over-year basis.
Trading Revenues: The performance of RJF’s trading business is expected to have been strong in the to-be-reported quarter, supported by increased client activity and market volatility. Trading conditions were shaped by evolving expectations surrounding artificial intelligence, ongoing geopolitical tensions, persistent inflationary pressures and a more hawkish Federal Reserve. These factors contributed to heightened volatility across equities and other asset classes, including commodities, fixed income and foreign exchange.
Net Interest Income (NII): In the to-be-reported quarter, the Fed raised interest rates by 25 basis points to 3.75-4.00% for the first time in more than three years because of persistently high inflation. However, this is less likely to have affected Raymond James’ NII numbers much in the quarter.
The lending scenario is likely to have normalized in the September-end quarter, which, along with stabilizing funding/deposit costs, is expected to have offered much-needed support to RJF’s NII.
The Zacks Consensus Estimate for NII is pegged at $567.1 million, indicating a year-over-year rise of 2.9%.
Based on static interest rates and assuming unchanged quarter-end balances and net of the fiscal fourth-quarter fee billing collection of $2.1 billion, the company expects the aggregate of NII and Raymond James Bank Deposit Program (RJBDP) third-party fees in the fourth fiscal quarter to be flat sequentially.
Expenses: Raymond James consistently hires advisors and invests in franchises. Thus, overall expenses are expected to have increased in the to-be-reported quarter. Due to a highly competitive environment and inflationary pressure, expenses are likely to have risen.
For fiscal 2026, management expects non-compensation expenses, excluding the bank loan loss provision for credit losses, unexpected legal and regulatory items, and non-GAAP adjustments to be $2.3 billion, representing 8% year-over-year growth.
What the Zacks Model Unveils for Raymond JamesAccording to our proven model, the chances of RJF beating the Zacks Consensus Estimate for earnings this time are low. This is because it does not have the right combination of two key ingredients — a positive Earnings ESP and a Zacks Rank #3 (Hold) or better.
You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Earnings ESP: The Earnings ESP for Raymond James is -0.82%.
Zacks Rank: The company currently has a Zacks Rank #3.
Finance Stocks Worth ConsideringHere are a couple of finance stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time around.
Invesco (IVZ - Free Report) is scheduled to announce quarterly numbers on Oct. 27. The company has an Earnings ESP of +0.10% and carries a Zacks Rank #3 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Quarterly earnings estimates for Invesco have been revised marginally upward to 75 cents over the past week.
The Earnings ESP for Prosperity Bancshares (PB - Free Report) is +0.04%, and it carries a Zacks Rank #3 at present. The company is slated to report third-quarter 2026 results on Oct. 28.
Over the past seven days, the Zacks Consensus Estimate for Prosperity Bancshares’ quarterly earnings has been unchanged at $1.63 per share.
LANSING, Mich.--(BUSINESS WIRE)--Jackson National Life Insurance Company® (Jackson®), the main operating subsidiary of Jackson Financial Inc.1 (NYSE: JXN), today launched Jackson Fixed Index Accumulation™ and Jackson Fixed Index Accumulation™ Advisory, fixed index annuities that protect retirement savings while providing growth potential. Jackson Fixed Index Accumulation (commission-based) and Jackson Fixed Index Accumulation Advisory (fee-based) each offer 5- and 7-year options, giving consume.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Range Resources Corporation (NYSE: RRC) to EQT Corporation for 0.987 shares of EQT common stock for each share of Range common stock. Upon completion of the proposed transaction, Range shareholders are expected to own approximately 27% of the combined company. Halper Sadeh encourages Range shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachar.
EQT just agreed to buy Range Resources in an all-stock deal that would create a $50 billion Appalachian gas giant, and the early market reaction tells a complicated story about who wins and who waits.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Key Takeaways Twilio is expected to beat Q3'26 earnings estimates, with consensus EPS of $1.46, up 16.8% year over year.AI upgrades, new Conversations Layer tools and an expanded partner network could boost Twilio's Q3 results.Twilio faces pricing and carrier-cost pressure, while delayed enterprise IT spending could weigh on Q3 growth.
Twilio Inc. (TWLO - Free Report) is likely to surpass earnings estimates when it reports third-quarter 2026 results on Oct. 29, after market close.
Twilio anticipates non-GAAP earnings per share between $1.42 and $1.47. The Zacks Consensus Estimate for third-quarter earnings has remained unchanged at $1.46 per share over the past 60 days, suggesting an improvement of 16.8% from the year-ago quarter’s $1.25.
TWLO’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being approximately 14%.
For the third quarter, the company anticipates revenues between $1.505 billion and $1.515 billion. The Zacks Consensus Estimate for revenues is pegged at $1.51 billion, indicating an increase of 16.3% from the year-ago quarter’s revenues of $1.30 billion.
Factors Likely to Influence TWLO’s Q3 ResultsTwilio’s third-quarter results are likely to reflect gains from sustained digital transformation efforts as enterprises continue to reconfigure their setup for a hybrid operational environment. TWLO’s initiatives to expand its network with independent software vendors and global partners are likely to have positively impacted the third-quarter performance.
New product launches, including rich communication services and artificial intelligence (AI) enhancements, particularly with the integration of OpenAI’s Realtime API into Twilio’s platform, are expected to contribute to the to-be-reported-quarter’s results. Its new Conversations Layer includes Conversation Memory, Conversation Orchestrator, Conversation Intelligence, Conversation Relay and Agent Connect. These products are likely to have attracted more customers in the third quarter.
Solutions like Twilio Conversations, SendGrid Ads and SendGrid’s Email Validation application programming interface may have contributed to the third-quarter performance. The company’s integration of AI in several communication and segment products is expected to have favored its third-quarter 2025 performance.
Nonetheless, its communications business faces pricing and carrier-cost pressure, which is anticipated to have negatively impacted third-quarter profitability. In the second quarter of 2026, the cost of revenues rose to $773.2 million from $625.7 million a year earlier, while GAAP gross margin was about 48% versus roughly 49% in the prior-year quarter. Twilio can pass certain A2P fees through to customers, but network cost changes and product mix can still limit gross margin expansion.
Ongoing macroeconomic challenges are likely to have hurt TWLO’s top line in the to-be-reported quarter. Enterprises are postponing their large IT spending plans due to a weakening global economy amid ongoing macroeconomic and geopolitical issues.
What the Zacks Model Unveils for TWLOOur proven model predicts an earnings beat for Twilio this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat, which is the case here.
Earnings ESP: Twilio has an Earnings ESP of +1.71% at present. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: TWLO currently carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Other Stocks With the Favorable CombinationHere are some other stocks worth considering, as our model shows that these also have the right combination of elements to beat on earnings this reporting cycle.
Seagate Technology (STX - Free Report) has an Earnings ESP of +2.07% and sports a Zacks Rank #1 at present. Seagate Technology is set to report first-quarter fiscal 2027 results on Oct. 27.
The Zacks Consensus Estimate for Seagate Technology’s first-quarter fiscal 2027 earnings is pegged at $7.44 per share, up by 10 cents over the past seven days, indicating a rise of 185.1% from the year-ago quarter’s reported figure.
Amphenol (APH - Free Report) has an Earnings ESP of +1.72% and carries a Zacks Rank #2 at present. Amphenol is set to report third-quarter 2026 results on Oct. 28.
The Zacks Consensus Estimate for Amphenol’s third-quarter 2026 earnings is pegged at 73 cents per share, up by a penny over the past seven days, calling for a jump of 55.3% from the year-ago quarter’s reported figure.
Corning (GLW - Free Report) has an Earnings ESP of +0.34% and a Zacks Rank #2 at present. Corning is slated to report third-quarter 2026 results on Oct. 27.
The Zacks Consensus Estimate for Corning’s third-quarter 2026 earnings is pegged at 89 cents per share, up by a penny over the past seven days, suggesting an increase of 32.8% from the year-ago quarter’s reported figure.
SummaryBaron Real Estate Income Fund decreased 7.58% (Institutional Shares) in the third quarter, underperforming the MSCI US REIT Index, which decreased 6.33%.Welltower is a leading owner and operator of senior housing communities across the U.S., Canada, and the U.K., and is the largest health care REIT by market capitalization.We initiated a position in AAON, Inc., following a disappointing second quarter earnings result.Despite the quarterly pullback, The Macerich Company's management continues to execute well, tracking ahead of targets on leasing, occupancy, space buildouts, select dispositions, and debt paydown. courtneyk/iStock via Getty Images
The following segment was excerpted from Baron Real Estate Income Fund Q3 2026 Shareholder Letter.
Top Contributors and Detractors Top contributors to performance for the quarter
Quarter End Market Cap($B) Contribution to Return(%) Welltower
On October 26, 2026, we conducted a DCF analysis for ARM Holdings PLC (ARM), a company that has seen significant price fluctuations recently. The stock has expe
Arm's stock has shed half its value while its three core revenue engines keep accelerating, leaving investors to decide whether a brutal sell-off signals a buying opportunity or a warning sign about what comes next.
Harley-Davidson (NYSE:HOG | HOG Price Prediction) reports third-quarter results on October 29, 2026. Shares are up 44.88% year to date, so this report will show whether the “Back to the Bricks” turnaround has earned that rally.
CINCINNATI & BRENTWOOD, Tenn.--(BUSINESS WIRE)--HealthSpan Partners, a contractual affiliate and supporting organization of U.S.-based Bon Secours Mercy Health (“BSMH”), and Surgery Partners, Inc. (NASDAQ:SGRY), a leading short-stay surgical facility owner and operator, today announced a definitive agreement under which HealthSpan Partners will acquire Surgery Partners in an all-cash transaction valued at an enterprise value of approximately $5.7 billion. Under the terms of the agreement, Surge.
Apollo is finalizing a deal to buy nearly a 10% stake in Mubadala Capital, according to people familiar with the matter; the transaction has not yet been publicly announced. Mubadala Capital is the alternative asset management subsidiary of Abu Dhabi sovereign investor Mubadala Investment Company.
ABU DHABI, United Arab Emirates & NEW YORK--(BUSINESS WIRE)--Mubadala Capital, the alternative asset management arm of Mubadala Investment Company, today announced a strategic investment from Apollo (NYSE: APO) to support its next phase of growth. Building on their existing relationship, Apollo will take a minority equity stake in Mubadala Capital and commit capital across its various investment strategies, working alongside Mubadala Capital as it continues scaling a world-class alternative ass.
SAN DIEGO, Oct. 26, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Doximity, Inc. (NYSE: DOCS) common stock between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"), have until Monday, November 16, 2026 to seek appointment as lead plaintiff of the Doximity class action lawsuit. Captioned Michigan Laborers' Pension Fund v.
MIDLAND, Texas--(BUSINESS WIRE)---- $ASTS #AST--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced significant progress toward bringing space-based cellular broadband to Brazil, Latin America's largest economy. AST SpaceMobile has secured S-band spectrum authorization from Brazil's National Telecommunication.
BELLEVUE, Wash.--(BUSINESS WIRE)--Savers Value Village, Inc. (NYSE: SVV) (the “Company”) today announced that it will host an Innovation Day on Tuesday, November 10, 2026, from 9:00 a.m. to 1:00 p.m. CT in the Minneapolis–St. Paul area.The event will feature a tour of Savers' Minneapolis Centralized Processing Center (CPC) and a retail store tour. The attendees will get a firsthand look at the Company's innovation agenda spanning technology and operations, including demonstrations of ThriftIQ. T.
New York, New York--(Newsfile Corp. - October 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline. SO WHAT: If you purchased Hims securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Did you buy HIMS securities between August 4, 2025 and July 29, 2026?
Affected HIMS Investor Summary
Who: Hims & Hers Health, Inc. (NYSE: HIMS)What: Securities fraud class action lawsuit filedClass Period: August 4, 2025 through July 29, 2026Deadline to Seek Lead Plaintiff Status: November 2, 2026Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s deceptive and unlawful privacy practicesInvestor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options RADNOR, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. (HIMS) (NYSE: HIMS) on behalf of those who purchased or acquired HIMS securities between August 4, 2025 and July 29, 2026, inclusive. The lawsuit is filed in the United States District Court for the Northern District of California and is captioned Velanki v. Hims & Hers Health, Inc., No. 3:26-cv-09313 (N.D. Cal.). Investors have until November 2, 2026, to file for lead plaintiff status.
CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS:
If you purchased or acquired HIMS securities and have lost money on your investment, please provide your information here:
To view the HIMS video on YouTube, click here: https://youtu.be/zCS_-D0Ocv4
You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected]. There is no cost or obligation to speak with an attorney.
HIMS & HERS HEALTH, INC. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY:
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) HIMS shared consumers’ health information with third-party advertising platforms; (2) HIMS charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is “right for them;” (3) the foregoing conduct subjected HIMS to regulatory scrutiny; (4) as a result, HIMS was reasonably likely to incur fees and penalties; and (5) as a result of the foregoing, Defendants’ positive statements about the company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Why did HIMS’s Stock Drop?
On July 29, 2026, the Federal Trade Commission (“FTC”) filed a lawsuit against HIMS accusing the company of sharing customers' medical information with third-party advertisers. Specifically,
the FTC’s criminal complaint accuses HIMS of "deceptive and unlawful privacy practices," including sharing sensitive details about a patient's health with Snap and Facebook parent, Meta Platforms. On this news, HIMS’s stock price declined $4.32 per share, or 14.73%, to close at $25.00 per share on July 29, 2026.
WHAT HIMS & HERS HEALTH, INC. INVESTORS CAN DO NOW:
File to be lead plaintiff by November 2, 2026.Contact KTMC for a free case evaluation. All representation is on a contingency fee basis, there is no cost to you.Retain counsel of choice or take no action. THE LEAD PLAINTIFF PROCESS FOR HIMS & HERS HEALTH, INC. INVESTORS:
HIMS investors may, no later than November 2, 2026, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.
Kessler Topaz Meltzer & Check, LLP encourages HIMS investors to contact the firm for more information.
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC):
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including being recognized in Chambers & Partners USA 2026 as a Band 1 Top Firm in Securities and Class Actions, Legal 500’s Tier 1 Rankings for Securities and M&A Litigation, The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent. The complaint in this matter was not filed by KTMC.
CONTACT:
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087 [email protected]
May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.
LOS ANGELES, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: August 4, 2025 to July 29, 2026
DEADLINE: November 2, 2026
If you are a shareholder who suffered a loss, click here to participate.
CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Hims & Hers provided customer health data to third-party advertising platforms. The Company’s treatment practices were likely to result in heightened regulatory scrutiny. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Hims & Hers, investors suffered damages.
We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
Join the case to recover your losses
WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
Schall, Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com
Office: 310-301-3335 [email protected]
Reddit reports its latest quarterly results on Thursday afternoon. There are valid concerns, but engagement and improving monetization continue to deliver monster growth.
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European Union's In Vitro Diagnostic Regulation (IVDR) as a Class C in vitro diagnostic device. The certification covers Tempus' quality management system for "next-generation sequencing devices for cancer genomic profiling to support clinical management." xR detects gene rearrangements and specific splice variants in solid tumor tissue to support clinical management. A.
QUEBEC CITY--(BUSINESS WIRE)--iA Financial Group (iA Financial Corporation Inc. (TSX: IAG)) will disclose its 2026 third quarter earnings results on Monday, November 9, 2026, after market close. Management will present these results during a conference call to be held the following day, Tuesday, November 10, 2026, at 11:00 a.m. (ET). To listen to the conference call, simply dial in using one of the following methods: Live Webcast: Click here (https://www.gowebcasting.com/15009) or go to the iA.
Atlas Energy Solutions (NYSE: AESI - Get Free Report) will likely be announcing its Q3 2026 results after the market closes on Monday, November 2nd. Analysts expect Atlas Energy Solutions to post earnings of ($0.2387) per share and revenue of $264.71 million for the quarter. Investors can check the company's upcoming Q3 2026 earnings report for
GEV's Q3 outlook reflects surging power demand, a $176 billion backlog and grid investments, while wind weakness and tariff uncertainty pose challenges.
Lula's surprise return to Brazil's presidency blindsided investors who had positioned for the opposite outcome, and the fallout is carving deep losses into some of the most widely held Brazilian names trading in the U.S.
Brazil’s surprise election result is hitting the country’s U.S.-listed companies hardest where government policy and borrowing costs carry the most weight. Nu Holdings (NYSE:NU | NU Price Prediction) stock is down 25% to $11.30 in morning trading, a drop that marks the market’s toughest verdict on Brazil’s financial-services outlook.
Meanwhile, Petrobras (NYSE:PBR) stock is sliding 21% to $20.54, trailing only Nu Holdings among the three companies, as the state-controlled oil producer faces fresh questions about government influence. MercadoLibre (NASDAQ:MELI) shares are falling 15% to $1,545, a smaller decline than either Nu Holdings or Petrobras.
The selling pressure is landing directly on Brazil. Tracking a broad basket of Brazilian equities, the iShares MSCI Brazil ETF (NYSEARCA:EWZ) is down 28% to $30.66, a deeper slide than any of the three companies. For comparison, the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is up 0.3% to $762.13, showing that risk appetite outside of Brazil is holding steady.
Lula’s Fourth-Term Upset Catches Markets Off Guard Luiz Inácio Lula da Silva won Brazil’s presidential runoff over the weekend, a surprise victory that gives him a fourth term and sends a shock through Nu Holdings, Petrobras and MercadoLibre shares. Senator Flávio Bolsonaro, who led the first round earlier this month, has refused to concede, adding further political uncertainty.
Investors had largely positioned for a Bolsonaro win and the economic reforms it was expected to bring. Brazil is dealing with deteriorating public finances and elevated interest rates. Whether Lula’s more gradual approach to fiscal repair can still bring borrowing costs down is now the central question hanging over Brazilian assets.
Nu Holdings and Petrobras Absorb the Heaviest Blows Nu Holdings is a digital financial services platform operating primarily in Brazil, Mexico and Colombia, with the majority of its customers in Brazil. That footprint ties the company directly to Brazilian interest rates, consumer credit conditions and the tax treatment of financial services. Lula’s win stokes fears of further tax hikes and heavier regulation on Brazilian lenders, and as a result Nu Holdings stock is leading the decline.
Petrobras is Brazil’s state-controlled integrated oil company, with the national government as its controlling shareholder. Such a structure makes the oil producer sharply sensitive to the presidency, with the selloff reflecting fears of renewed state intervention, fuel-price controls, higher taxation, and dividend policy risk. A new crude export tax and fuel subsidy obligations already weigh on the company, though its large deepwater and pre-salt production base still gives Petrobras a solid operating foundation.
MercadoLibre runs e-commerce and fintech businesses across Brazil, Mexico, Argentina and other Latin American markets. Yet, Brazil is its largest market, which leaves the company highly sensitive to a weaker real and local policy risk. Its wider reach hasn’t saved it a steep decline, though MercadoLibre stock is holding up better than the two names most tied to Brasília.
What Lula’s Win Means for Nu Holdings, Petrobras and MercadoLibre Next up for MercadoLibre is its quarterly report, expected in early November, though the company hasn’t yet confirmed the date. That report is the next test of whether Brazilian demand holds up after the election. Steady order growth in the results could help MercadoLibre stock separate from the wider Brazil selloff.
For Nu Holdings and Petrobras, the clearest signals could come from how quickly Lula’s government outlines its fiscal repair plan and from fresh tax measures on Brazilian financial services. Any shift in Petrobras’ pricing or dividend policy could also sway its shares.
With the iShares MSCI Brazil ETF falling harder than any single company, the political shock is clearly spreading across the country’s equities. Those weighing exposure to Nu Holdings, Petrobras and MercadoLibre shares should adjust their holdings carefully given the unresolved fiscal and policy questions hanging over Brazil.
Contact [email protected] for any questions or corrections.
BEAVERTON, Ore.--(BUSINESS WIRE)--Digimarc Corporation (NASDAQ: DMRC), a leading provider of digital identity and authentication technologies, today announced strong market momentum for its gift card security solution following a highly successful week at the 2026 Retail Gift Card Association (RGCA) industry event in Denver, CO. Digimarc's cross-functional team of five experts specializing in retail technology, digital identity, and fraud prevention engaged in dozens of strategic discussions wi.
Diversified Healthcare Trust (NASDAQ: DHC - Get Free Report) is anticipated to issue its Q3 2026 results after the market closes on Monday, November 2nd. Analysts expect Diversified Healthcare Trust to post earnings of ($0.15) per share and revenue of $370.87 million for the quarter. Interested persons may review the information on the company's upcoming Q3
PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NASDAQ: QBTS), (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software, and services, today announced that management will be participating in the following investor conferences: 2026 Cantor Convergence Conference on November 11, 2026 in Miami, Florida BMO Technology and Innovation Leaders Conference on November 12, 2026 in New York City RBC Capital Markets Gl.
Following the artificial intelligence (AI) boom, quantum computing stocks are touted as the next big opportunity due to the transformative potential of the technology.
Quantum computing remains an emerging industry, with companies racing to develop systems capable of solving problems beyond the practical reach of conventional computers.
Progress in hardware, error correction and commercial applications could attract investor interest over the next 12 months.
Against this backdrop, Finbold has identified two quantum computing stocks with speculative upside, with the potential of turning $10 into $100 in a year. Notably, neither stock is guaranteed to deliver that return
Rigetti Computing (NASDAQ: RGTI) Rigetti (NASDAQ: RGTI) is developing superconducting quantum processors and integrated computing systems for applications that could benefit from advanced computational capabilities.
Despite the technology’s potential, RGTI stock has struggled over the past year. At press time, shares traded at $11.52, down 52% year to date.
RGTI YTD stock price chart. Source: Google Finance Rigetti’s latest financial results show commercial activity, although revenue remains small relative to operating costs. In its second-quarter 2026 results, published on August 6, the company reported revenue of $5.1 million and an operating loss of $28.1 million.
It ended June with $541.3 million in cash, cash equivalents, and available-for-sale investments to fund research and development and commercial expansion.
The company is also pursuing practical high-performance computing applications. Its collaboration with Hewlett Packard Enterprise and the Pittsburgh Supercomputing Center aims to develop a hybrid quantum-classical supercomputing environment.
Rigetti is also pursuing a potential U.S. Department of Commerce funding arrangement worth up to $100 million over three years, subject to the terms of its announced letter of intent.
However, operating losses, research costs, and the challenge of improving processor performance remain significant risks.
D-Wave Quantum (NYSE: QBTS) D-Wave (NYSE: QBTS) specializes in quantum annealing systems designed to solve optimization problems involving scheduling, logistics, and resource allocation. Their usefulness depends on the application and how they compare with conventional alternatives.
QBTS shares have also struggled, trading at $11.60 at press time, down 58% in 2026.
QBTS YTD stock price chart. Source: Google Finance The company’s second-quarter 2026 results showed a sharp increase in customer bookings despite lower revenue.
D-Wave recorded $35.5 million in bookings in the first half of 2026, up from $2.9 million in the same period of 2025. Its remaining performance obligations reached $40.7 million at June 30, a 668% year-over-year increase.
The figures suggest that contracted demand is growing ahead of revenue recognition. More than half of D-Wave’s first-half revenue came from commercial customers, while commercial enterprises accounted for over 50% of its customers during the period.
Nevertheless, first-half revenue fell to $5.9 million from $18.1 million a year earlier, partly because of a $13.7 million system sale recognized in 2025, highlighting revenue volatility.
D-Wave’s upside depends on converting bookings into revenue, attracting more commercial customers and demonstrating cost-effective applications. New contracts and stronger financial results could improve investor sentiment.
However, inconsistent revenue, rising costs and slower-than-expected adoption remain key risks. Strong bookings alone do not guarantee a share-price increase, let alone a tenfold return.
On October 26, 2026, we delve into the DCF analysis for The Toronto-Dominion Bank (TD), a financial institution that has shown impressive price performance rece
Elon Musk said that many neocloud companies face "guppy-level death." Bloomberg/Getty Images Neocloud companies are sliding even lower.
Shares dropped further on Monday after Elon Musk warned that many of them face "guppy-level death."
CoreWeave and Nebius have both fallen more than 30% over the past month, largely due to growing concerns about the debt they've taken on to build more data centers.
In early premarket trading on Monday, CoreWeave was down another 5%, and Nebius was down 3%, though those losses pared somewhat as the opening bell approached. Iren, another publicly traded neocloud, saw a near 3% premarket drop Monday.
The declines follow a string of X posts from Musk on Sunday evening questioning the neocloud business model.
"As of the past few weeks, debt markets have almost entirely shut off access to money for any company that doesn't have substantial revenue independent of AI data centers," he said.
"That means the 200+ neoclouds are going to see guppy-level death and consolidation," he added. "Some will make it through, but not many."
Musk said that while SpaceX has closed $40 billion in debt to buy GPUs, his company makes money through Starlink and rocket launches.
Meanwhile, investors are worried that a slowing AI boom could leave debt-heavy neoclouds struggling to service their loans.
After one X user posted arguing that Musk was trying to drive down the share prices of neocloud companies to acquire them, Musk replied: "SpaceX is not buying any neoclouds. Pointless."
Nvidia CEO Jensen Huang remains bullish about the sector. "The demand for the neoclouds is off the charts," he told CNBC last Thursday.
Nvidia holds significant stakes in CoreWeave, Nebius, and other cloud-computing companies.
However, a recent Bernstein Research report analyzed thousands of planned US data centers and estimated that only about 35% of the announced capacity will be built.
"Press releases are cheap … concrete is not," Bernstein analysts wrote in a research note.
Read next
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Pete Syme You're currently following this author! Click to unsubscribe from email alerts.
Pete Syme is an aviation reporter for Business Insider, based in London.He writes about all things related to the industry, from aviation safety and CEO interviews to route reveals and airplane tours. Pete also uses data for industry analyses and to visualize breaking news events.Before joining Business Insider in 2022, he graduated with an MA in Newspaper Journalism from City, University of London, and a BA in English from the University of Exeter.
SummaryCoreWeave remains a Strong Buy despite a reduced 2027 price target of $179, reflecting higher unsecured debt costs and increased dilution risk.CRWV’s balance sheet repricing centers on $16.6B in unsecured debt now yielding close to 15%, impacting valuation multiples and equity funding requirements.Capacity is sold out with a $103.7B backlog, but 2027 funding needs require raising ~$33B, making financing—not demand—the critical variable for equity value.I am closely monitoring upcoming unsecured or convertible financings, at-the-market equity sales, EBITDA margins, and progress toward an investment-grade rating. pingingz/iStock via Getty Images
I have covered CoreWeave, Inc. (CRWV) twice, initiating with a strong buy and a roughly $250 price target in early July and maintaining both after the second-quarter results, and this piece is prompted by the 14 October selloff, in which the shares fell
106 Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of CRWV, NBIS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Shares of major neocloud companies CoreWeave CRWV, Nebius and Iren fell during premarket trading on Monday after Elon Musk warned that more than 200 firms in the sector could face failures and consolidation as access to financing tightens. Iren shares fell roughly 3%, while CoreWeave dropped around 5% and Nebius declined more than 2%.
fuboTV (NYSE: FUBO - Get Free Report) is expected to be announcing its results before the market opens on Monday, November 2nd. Analysts expect the company to post earnings of ($0.4145) per share and revenue of $1.50 billion for the quarter. fuboTV (NYSE: FUBO - Get Free Report) last announced its earnings results on Wednesday, August 5th.
NEW YORK--(BUSINESS WIRE)--FuboTV Inc. (NYSE: FUBO) today announced that it will issue financial results for its fiscal full year and fourth quarter 2026 before the market opens on Tuesday, November 17, 2026.
Following the release, Fubo CEO Alisa Bowen and CFO John Janedis will host a conference call to review results and provide a business update.
Conference Call Details:
Date: Tuesday, November 17, 2026
Start Time: 9:30 a.m. ET
Dial-In Details:
North America (Toll-Free): 1-833-461-5787
International (Toll): +1-585-542-9983
Meeting ID: 556 358 593
The webcast will also be available on the Events & Presentations page of Fubo’s investor relations website. Participants should join the webcast 10 minutes in advance to ensure that they are connected prior to the event. An archived replay will be available on Fubo’s investor relations website following the call.
About FuboTV Inc.
FuboTV Inc. (NYSE: FUBO) is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming through a best-in-class user experience that offers greater choice, flexibility and value. The sixth largest Pay TV company in the U.S. (UBS estimates) and ranked among Fast Company’s Most Innovative Companies (2026) and the Financial Times’ The Americas’ Fastest-Growing Companies (2026, 2025), FuboTV Inc. owns Hulu + Live TV (entertainment), Fubo (sports) and Molotov (entertainment and sports), which stream in markets around the globe. FuboTV Inc. is an affiliate of The Walt Disney Company.
HOBOKEN, N.J., Oct. 26, 2026 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), a vertically integrated quantum company pioneering photonics and semiconductor manufacturing, today announced that the Company will host a conference call and webcast on Monday, November 9, 2026 at 4:30 p.m.
Bitmine repurchased 2.04 million shares in the past week Bitmine has repurchased a cumulative 22.9 million shares so far in 2026, the largest ever crypto treasury company equity buyback executed Bitmine owns 4.95% of the total ETH coin supply of 122.2 million Bitmine is 99% of the way to the 'Alchemy of 5%' in just 15 months Bitmine released Chairman's Message on October 7 titled "Crypto Bull Underway — This Cycle Likely the Largest" Bitmine was added to the Russell 1000 Large-cap index on June 26, 2026 Bitmine's Series A Preferred Stock is trading on the NYSE under the symbol BMNP Bitmine has 5,227,037 staked ETH, representing $12.3 billion at $2,356 per ETH. MAVAN (Made in America VAlidator Network) is a premier Ethereum staking destination for BMNR and institutional investors Bitmine owns $76 million of Eightco (NASDAQ: ORBS), now one of the only publicly listed equities in the world to provide investors indirect exposure to OpenAI Bitmine Crypto + Total Cash Holdings & Marketable Securities + "Moonshots" total $15 billion, including 6.05 million ETH tokens, total cash & marketable securities of $514 million, and other crypto holdings Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH NORWALK, Conn.
